Robert Solinga

Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit

Robert Busby, Alexander P. Bryant, Wilmin Bartolini et al. · European Journal of Pharmacology · 2010 · 248 citations

Life Sciences, Pharmacology, Physiology +13

Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract

Alexander P. Bryant, Robert Busby, Wilmin Bartolini et al. · Life Sciences · 2010 · 224 citations

Medicine, Pharmacology, Gastroenterology +9

Immunization with <i>Staphylococcus aureus</i> Clumping Factor B, a Major Determinant in Nasal Carriage, Reduces Nasal Colonization in a Murine Model

Adam C. Schaffer, Robert Solinga, Jordan L. Cocchiaro et al. · Infection and Immunity · 2006 · 170 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

Robert Busby, Marco M. Kessler, Wilmin Bartolini et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 136 citations

Medicine, Pharmacokinetics, Pharmacology +17

CD4 ⁺ T cells and CXC chemokines modulate the pathogenesis of <i>Staphylococcus aureus</i> wound infections

Rachel M. McLoughlin, Robert Solinga, Jeremy Rich et al. · Proceedings of the National Academy of Sciences · 2006 · 116 citations · Full text

Veterinary Medicine, Immunology, Microbiology +17